AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
JBS
ACCE-researched

JBS N.V. Class A Common Shares (JBS) fair value

Consumer Defensive · Packaged Foods · NYSE · United States
$12.42+0.40%
Market cap $13.2BNext earnings 2026-11-09Updated Oct 23, 2026
Add earnings to calendarGoogle
Our verdict
Trades 265% above our fair value
Price
$12.42
Model fair valueConfidence: medium
$3.41
Only one of our models could value this stock with confidence, so use it as a guide.
Not used by alerts or posts.
Valued as a mature, profitable company: P/E comparison and Dividend discount.
ACCE opinionJBS N.V. Class A Common Shares (JBS)
Fair value (2 models)
Not available
ACCE price target
$14.50
Rating
Not rated
Horizon
12 months
ACCE price target published on 18 Oct 2026, 01:52 CEST; previously $13.00 since 26 Sept 2026, 00:00 CEST.
Price used: $12.42 at the close on 23 Oct 2026, 22:00 CEST.
Models: Dividend discount and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
50
out of 100
Analysts
87% buy
15 covering
P/E
11.6x
forward 3.9x
1-year return
-3.7%
Dividend yield
8.02%

JBS N.V. Class A Common Shares in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

JBS N.V. is the world's largest meat processor by volume, selling beef, pork, poultry and prepared foods under brands including Seara and Pilgrim's Pride across the Americas, Australia and Europe. Its edge is scale: running more plants and handling more livestock than any rival gives it procurement and distribution advantages that smaller packers struggle to match, though its thin 3.1% operating margin and 11.8% gross margin show how little of that scale translates into pricing power. Revenue growth of 13.8% is the main near-term story, and the stock trades at 9.7 times forward earnings against 12.0 times trailing, implying the market expects earnings to rise. Those multiples look undemanding for a company with a 13.4% return on equity, but the low-margin, commodity-linked profile means earnings can swing sharply with cattle and grain costs. The score of 52/100 and absence from major indices suggest the name merits a deeper look at margin durability before anything else.

AI-assisted·How I use AIWritten Oct 13, 2026
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
  • high
    Earnings collapse
    YoY earnings down 57.2% despite 13.8% revenue growth. Margin compression across operating (3.1%) and net (1.2%) levels signals profitability crisis.
  • high
    Leverage and FCF mismatch
    Debt/Equity 2.63 is elevated for packaged foods. FCF of $4.1B appears strong but must service significant debt burden; sustainability unclear.
  • moderate
    Quality score deterioration
    ACCE Quality score 35/100 is weak. Combined with G:40, suggests operational and governance concerns beyond the earnings miss.
  • moderate
    High short interest
    17.9% short position is material for a $13.9B cap. Reflects investor skepticism about the earnings recovery narrative.

AI research notes

AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Stock trades at 3.9x forward earnings, well below the 18.1x sector median, suggesting deep undervaluation.
  • Company generated 4.1B dollars in free cash flow last year and trades at a 29.7% free cash flow yield.
  • Diluted share count fell 51.8% last fiscal year while ROE reached 13.4%, boosting per-share value.
Why it could disappoint
  • Forward P/E of 3.9x implies only 2.0% annual cash flow growth over the next five years.
  • Net margin of 1.2% and ROIC of 5.2% show the business generates thin returns on capital deployed.
  • Debt to equity of 2.63 leaves little room for error if commodity cycles or disease outbreaks hit earnings.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 9, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where JBS's valuation models land
Price
$12.42
Model fair valueConfidence: medium
$3.41
Model
Fair value
Upside
Dividend discount
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish87% buy · 15 covering analysts
● Strong buy 8● Buy 5● Hold 2● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-4.7%
1 month
+7.9%
3 months
+1.1%
6 months
-25.3%
YTD
-13.9%
1 year
-3.7%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
18 Oct 2026, 01:52 CESTACCE price target$14.50$13.00$13.03
9 Oct 2026, 00:00 CESTFair value$22.61$27.65$12.24
26 Sept 2026, 00:00 CESTACCE price target$13.00first publication$11.36
11 Aug 2026, 00:00 CESTFair value$27.65$25.96$14.23
10 Aug 2026, 00:00 CESTFair value$25.96$27.70$14.23
9 Aug 2026, 00:00 CESTFair value$27.70$27.05$14.23
7 Aug 2026, 00:00 CESTFair value$27.05$26.65$13.64
5 Aug 2026, 00:00 CESTFair value$26.65$29.11$13.61
29 Jul 2026, 00:00 CESTFair value$29.11$27.22$13.51
22 Jul 2026, 00:00 CESTFair value$27.22$28.43$11.98

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full JBS page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth40Value100Quality35Momentum25Total50
Valuation
Trailing P/E
11.6x
Forward P/E
3.9x
PEG
no data
P/B
4.60x
EV / Revenue
0.4x
Book value/sh
$7.68
Enterprise value
$33.3B
Profitability
ROE
13.4%
FCF yield
30.92%
ROIC
5.2%
Health and risk
Debt / equity
2.63
Dividend yield
8.02%
Beta
no data

Price

-2.1% · 1Y

Ask anything about JBS

Answered from JBS N.V. Class A Common Shares fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 83% of peers
low 8.4x11.6xhigh 60.7x
ROEbetter than 80% of peers
low 4%13%high 23%
Div yieldbetter than 100% of peers
low 1.8%8.0%high 8.0%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
JBS JBS N.V. Class A Common Shares$12.42--11.6x13.4%3550
MKC McCormick & Company Incorporated Common Stock$48.71$459% above8.4x22.6%7658
SJM The J.M. Smucker Company Common Stock$133.39$15313% below60.7x3.9%5060
BIMBOA.MX Grupo BimboMXN 59.94MXN 5116% above22.9x11.6%5556
HRL Hormel Foods Corporation Common Stock$21.36$21At fair value32.9x4.3%4739
BRITANNIA.NS Britannia Industries Limited₹4625.00--42.0x-8545
SAP.TO Saputo Inc.C$41.05C$3324% above23.5x10.4%4450

Sector report card

Where JBS ranks against its sector peers on each metric.

Computing percentiles…
  • GlobeNewswire•Oct 13, 2026
    Pilgrim’s Pride Corporation to Host Third Quarter Earnings Call on October 29, 2026
  • GlobeNewswire•Oct 9, 2026
    Pilgrim’s Pride Forms Special Committee and Selects Advisors to Review JBS N.V. Proposal
  • Business Wire•Aug 18, 2026
    JBS Announces Proposal to Acquire Remaining Publicly Traded Shares of Pilgrim’s Pride Corporation
2 more press releases · full archive on Investor+.INVESTOR
30 filings of 40
September 2026
Sep 15
8-KCurrent reportPeriod 2026-09-15
View on SEC →
August 2026
Aug 25
Form 4Insider transactionPeriod 2026-08-24
View on SEC →
Aug 19
8-KCurrent reportPeriod 2026-08-18
View on SEC →
27 more filings + AI summaries on Investor+.INVESTOR